Cytosorbents Corporation Common Stock (NASDAQ: CTSO) last traded at $3.82, up 0.79% on the session. The quote above updates while this page is open; the figures below are drawn from Cytosorbents Corporation Common Stock’s own filings and are restated only when a new one is published.
Cytosorbents Corporation Common Stock trades on NASDAQ under the ticker CTSO. Its market capitalisation is $240.06 million.
Valuation measures for Cytosorbents Corporation Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $240.06M |
|---|---|
| Enterprise value | $274.36M |
| Price / sales | 6.45 |
| Beta | 1.20 |
Trailing-twelve-month figures tagged in Cytosorbents Corporation Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $37.22M |
| Net income (TTM) | -$18.21M |
|---|
| EPS (TTM) | -$0.290 |
|---|
| Gross margin | 71.61% |
|---|
| Operating margin | -34.74% |
|---|
| Cash | $4.41M |
|---|
Range and volume for CTSO over the past 52 weeks.
| 52-week high | $19.72 |
|---|---|
| 52-week low | $3.59 |
| Volume | 2.6K |
| Average volume | 12.4K |
| Previous close | $3.79 |
Invest a chosen dollar amount in Cytosorbents Corporation Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CTSO.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.